Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: A randomized controlled trial

Journal of the American Heart Association

Volumn 3, Issue 5, 2014, Pages

  Gardner, Andrew W ^a,d   Parker, Donald E ^c   Montgomery, Polly S ^a   Blevins, Steve M ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b General Internal Medicine Section Departments of Medicine   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Claudication; Exercise; Peripheral vascular disease

Indexed keywords

C REACTIVE PROTEIN;

AGED; ARTICLE; CALF MUSCLE HEMOGLOBIN OXYGEN SATURATION; CLAUDICATION ONSET TIME; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DAILY AMBULATORY ACTIVITY; EXERCISE; FEMALE; HOME MONITORING; HUMAN; INFLAMMATION; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; MOBILIZATION; OUTCOME ASSESSMENT; PEAK WALKING TIME; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SUBMAXIMAL EXERCISE PERFORMANCE; TREADMILL EXERCISE; VASCULAR FUNCTION; AGE; ANALYSIS OF VARIANCE; BODY MASS; COMPARATIVE STUDY; EXERCISE TOLERANCE; HOME CARE; KINESIOTHERAPY; MIDDLE AGED; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PERIPHERAL ARTERIAL DISEASE; PHYSIOLOGIC MONITORING; PHYSIOLOGY; PROCEDURES; QUALITY OF LIFE; REFERENCE VALUE; SEVERITY OF ILLNESS INDEX; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VASCULAR PATENCY; WALKING;

AGE FACTORS; AGED; ANALYSIS OF VARIANCE; BODY MASS INDEX; EXERCISE; EXERCISE THERAPY; EXERCISE TOLERANCE; FEMALE; HOME CARE SERVICES; HUMANS; INFLAMMATION; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PATIENT COMPLIANCE; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; QUALITY OF LIFE; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; WALKING;

EID: 84924416874     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.001107     Document Type: Article

References (28)

1. Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-1340.
2. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 2008;13:209-215.
3. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
4. Gardner AW, Skinner JS, Cantwell BW, Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991;23:402-408.
5. McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286:1599-1606.
6. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA. 1995;274:975-980.
7. Gardner AW, Parker DE, Montgomery PS, Scott KJ, Blevins SM. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011;123:491-498.
8. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Intersociety consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5-S67
9. Hiatt WR, Marshall JA, Baxter J, Sandoval R, Hildebrandt W, Kahn LR, Hamman RF. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. J Clin Epidemiol. 1990;43:597-606.
10. Gardner AW. Reliability of transcutaneous oximeter electrode heating power during exercise in patients with intermittent claudication. Angiology. 1997;48:229-235.
11. Feinberg RL, Gregory RT, Wheeler JR, Snyder SO Jr, Gayle RG, Parent FN III, Patterson RB. The ischemic window: a method for the objective quantitation of the training effect in exercise therapy for intermittent claudication. J Vasc Surg. 1992;16:244-250.
12. Gardner AW, Parker DE, Webb N, Montgomery PS, Scott KJ, Blevins SM. Calf muscle hemoglobin oxygen saturation characteristics and exercise performance in patients with intermittent claudication. J Vasc Surg. 2008;48:644-649.
13. Womack CJ, Sieminski DJ, Katzel LI, Yataco A, Gardner AW. Improved walking economy in patients with peripheral arterial occlusive disease. Med Sci Sports Exerc. 1997;29:1286-1290.
14. Montgomery PS, Gardner AW. The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc. 1998;46:706-711.
15. Gardner AW, Montgomery PS, Scott KJ, Afaq A, Blevins SM. Patterns of ambulatory activity in subjects with and without intermittent claudication. J Vasc Surg. 2007;46:1208-1214.
16. Regensteiner JG, Steiner JF, Panzer RL, Hiatt WR. Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease. J Vasc Med Biol. 1990;2:142-152.
17. Ware JE Jr. The status of health assessment 1994. Annu Rev Public Health. 1995;16:327-354.
18. Gardner AW, Montgomery PS, Blevins SM, Parker DE. Gender and ethnic differences in arterial compliance in patients with intermittent claudication. J Vasc Surg. 2010;51:610-615.
19. Hiatt WR, Creager MA, Amato A, Brass EP. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. J Cardiopulm Rehabil Prev. 2011;31:125-132.
20. McDermott MM, Liu K, Guralnik JM, Criqui MH, Spring B, Tian L, Domanchuk K, Ferrucci L, Lloyd-Jones D, Kibbe M, Tao H, Zhao L, Liao Y, Rejeski WJ. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA. 2013;310:57-65.
21. Gardner AW, Skinner JS, Smith LK. Effects of handrail support on claudication and hemodynamic responses to single-stage and progressive treadmill protocols in peripheral vascular occlusive disease. Am J Cardiol. 1991;68:99-105.
22. Tew G, Nawaz S, Zwierska I, Saxton JM. Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci (Lond). 2009;117:405-413.
23. Brendle DC, Joseph LJ, Corretti MC, Gardner AW, Katzel LI. Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease. Am J Cardiol. 2001;87:324-329.
24. Gardner AW, Parker DE, Montgomery PS, Blevins SM, Teague AM, Casanegra AI. Monitored daily ambulatory activity, inflammation, and oxidative stress in patients with claudication. Angiology. 2013;65:491-496.
25. McDermott MM, Ferrucci L, Liu K, Criqui MH, Greenland P, Green D, Guralnik JM, Ridker PM, Taylor LM, Rifai N, Tian L, Zheng J, Pearce WH, Schneider JR, Vonesh E. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc. 2005;53:1688-1696.
26. Januszek R, Mika P, Konik A, Petriczek T, Nowobilski R, Nizankowski R. The effect of treadmill training on endothelial function and walking abilities in patients with peripheral arterial disease. J Cardiol. 2014;64:145-151.
27. Nowak WN, Mika P, Nowobilski R, Kusinska K, Bukowska-Strakova K, Nizankowski R, Jozkowicz A, Szczeklik A, Dulak J. Exercise training in intermittent claudication: effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells. Thromb Haemost. 2012;108:824-831.
28. Saetre T, Enoksen E, Lyberg T, Stranden E, Jorgensen JJ, Sundhagen JO, Hisdal J. Supervised exercise training reduces plasma levels of the endothelial inflammatory markers E-selectin and ICAM-I in patients with peripheral arterial disease. Angiology. 2011;62:301-305.